News
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board
Health & Biotech
Creso Pharma Q&A: Halucenex Life Sciences acquisition
Stockhead TV
Creso Pharma’s acquisition of Halucenex Life Sciences marks the first fully-owned psychedelic medicines company on the ASX
Health & Biotech
Creso Pharma enters psychedelics market with ‘transformational’ Canadian acquisition
Health & Biotech
Creso Pharma signs second North American distribution partner
Health & Biotech
Creso Pharma makes plans to enter US market with new partnership
Health & Biotech
Creso Pharma’s Canadian subsidiary gets four more cannabis orders totalling $500k
Health & Biotech
Creso Pharma enters vast new market with $2.5 million distribution agreement
Health & Biotech
Famed cannabis entrepreneur Bruce Linton explains what he sees in Creso Pharma
Health & Biotech
Creso Pharma brings marketing and sales of CannaQIX cannabis lozenge in-house
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
Creso Pharma’s Canadian cannabis subsidiary picking up speed with more purchase orders
Health & Biotech
Creso Pharma cheers as Australia allows over-the-counter CBD oil sales
Health & Biotech
Creso Pharma reports rapid growth in fourth quarter with 740% increase in sales
Health & Biotech
Your ultimate guide to ASX pet stocks
Health & Biotech
Creso Pharma experiencing strong demand for pet-health cannabis products
Health & Biotech